Multidimensional 1-Year Outcomes After Intensive Care Admission for Multisystem Inflammatory Syndrome in Children

OBJECTIVES:. The COVID-19 pandemic gave rise to uncertainty concerning potential sequelae related to a severe acute respiratory syndrome coronavirus 2 infection. This landscape is currently unfolding with studies reporting sequelae on various domains (physical, cognitive, and psychosocial), although...

Full description

Saved in:
Bibliographic Details
Main Authors: Thomas C. Seijbel, BSc, Levi Hoste, MD, Corinne M. P. Buysse, MD, PhD, Karolijn Dulfer, PhD, Filomeen Haerynck, MD, PhD, Matthijs de Hoog, MD, PhD, Naomi Ketharanathan, MD, PhD
Format: Article
Language:English
Published: Wolters Kluwer 2025-01-01
Series:Critical Care Explorations
Online Access:http://journals.lww.com/10.1097/CCE.0000000000001213
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832589736387018752
author Thomas C. Seijbel, BSc
Levi Hoste, MD
Corinne M. P. Buysse, MD, PhD
Karolijn Dulfer, PhD
Filomeen Haerynck, MD, PhD
Matthijs de Hoog, MD, PhD
Naomi Ketharanathan, MD, PhD
author_facet Thomas C. Seijbel, BSc
Levi Hoste, MD
Corinne M. P. Buysse, MD, PhD
Karolijn Dulfer, PhD
Filomeen Haerynck, MD, PhD
Matthijs de Hoog, MD, PhD
Naomi Ketharanathan, MD, PhD
author_sort Thomas C. Seijbel, BSc
collection DOAJ
description OBJECTIVES:. The COVID-19 pandemic gave rise to uncertainty concerning potential sequelae related to a severe acute respiratory syndrome coronavirus 2 infection. This landscape is currently unfolding with studies reporting sequelae on various domains (physical, cognitive, and psychosocial), although most studies focus on adults or only one domain. We sought to investigate concurrent sequelae on multiple domains 1 year after PICU admission for Multisystem Inflammatory Syndrome in Children (MIS-C). DESIGN:. Prospective cohort study. SETTING:. Two academic, tertiary referral hospitals in The Netherlands and Belgium. PATIENTS:. Patients (< 18 yr, n = 58) seen in-person 1-year after PICU admission for MIS-C. INTERVENTIONS:. None. MEASUREMENTS AND MAIN RESULTS:. Seventy MIS-C patients (62% male; median age, 10.0 [interquartile range, 7.4–13.0]) were admitted to the PICU, mostly (86%) due to (imminent) circulatory failure. The majority received IV immunoglobulins (95%), steroids (83%), and vasopressors and/or inotropes (72%). Invasive respiratory support and extracorporeal membrane oxygenation were necessary in 7% and 2%, respectively. All patients survived. Fifty-eight patients (83%) attended 1-year follow-up. Although most patients had normal functional performance scores (Pediatric Cerebral Performance Category, Pediatric Overall Performance Category, and Functional Status Score), 62% still experienced physical sequelae: fatigue (40%), headaches (27%), and decreased exercise tolerance (19%). Cognitive, behavioral, and psychological problems were reported in 14%, 13%, and 23%, respectively. This resulted in 22% requiring ongoing healthcare utilization, 9% not being able to return to full-time school attendance and cessation of hobbies in 7%. CONCLUSIONS:. This is the first 1-year outcome study of MIS-C PICU patients to include both physical and psychosocial characteristics. One year after PICU admission, most children had normalized functional performance as measured by three validated performance scores. However, many still reported a variety of multidimensional sequelae at 1-year follow-up impacting daily life. This emphasizes the importance of continued investigative efforts and multidisciplinary follow-up programs to better understand pathophysiology and contributing factors to the MIS-C disease trajectory and initiate patient-specific interventions to improve outcome and social participation.
format Article
id doaj-art-e92cde92d10a4475b0e71023490f328e
institution Kabale University
issn 2639-8028
language English
publishDate 2025-01-01
publisher Wolters Kluwer
record_format Article
series Critical Care Explorations
spelling doaj-art-e92cde92d10a4475b0e71023490f328e2025-01-24T09:19:27ZengWolters KluwerCritical Care Explorations2639-80282025-01-0171e121310.1097/CCE.0000000000001213202501000-00012Multidimensional 1-Year Outcomes After Intensive Care Admission for Multisystem Inflammatory Syndrome in ChildrenThomas C. Seijbel, BSc0Levi Hoste, MD1Corinne M. P. Buysse, MD, PhD2Karolijn Dulfer, PhD3Filomeen Haerynck, MD, PhD4Matthijs de Hoog, MD, PhD5Naomi Ketharanathan, MD, PhD61 Department of Neonatal and Pediatric Intensive Care, Division of Pediatric Intensive Care, Erasmus MC Sophia Children’s Hospital, Rotterdam, The Netherlands.2 Department of Pediatric Pulmonology, Infectious Diseases and Immune Deficiency, Centre for Primary Immune Deficiency Ghent, Jeffrey Modell Diagnosis and Research Centre, Ghent University Hospital, Ghent, Belgium.1 Department of Neonatal and Pediatric Intensive Care, Division of Pediatric Intensive Care, Erasmus MC Sophia Children’s Hospital, Rotterdam, The Netherlands.1 Department of Neonatal and Pediatric Intensive Care, Division of Pediatric Intensive Care, Erasmus MC Sophia Children’s Hospital, Rotterdam, The Netherlands.2 Department of Pediatric Pulmonology, Infectious Diseases and Immune Deficiency, Centre for Primary Immune Deficiency Ghent, Jeffrey Modell Diagnosis and Research Centre, Ghent University Hospital, Ghent, Belgium.1 Department of Neonatal and Pediatric Intensive Care, Division of Pediatric Intensive Care, Erasmus MC Sophia Children’s Hospital, Rotterdam, The Netherlands.1 Department of Neonatal and Pediatric Intensive Care, Division of Pediatric Intensive Care, Erasmus MC Sophia Children’s Hospital, Rotterdam, The Netherlands.OBJECTIVES:. The COVID-19 pandemic gave rise to uncertainty concerning potential sequelae related to a severe acute respiratory syndrome coronavirus 2 infection. This landscape is currently unfolding with studies reporting sequelae on various domains (physical, cognitive, and psychosocial), although most studies focus on adults or only one domain. We sought to investigate concurrent sequelae on multiple domains 1 year after PICU admission for Multisystem Inflammatory Syndrome in Children (MIS-C). DESIGN:. Prospective cohort study. SETTING:. Two academic, tertiary referral hospitals in The Netherlands and Belgium. PATIENTS:. Patients (< 18 yr, n = 58) seen in-person 1-year after PICU admission for MIS-C. INTERVENTIONS:. None. MEASUREMENTS AND MAIN RESULTS:. Seventy MIS-C patients (62% male; median age, 10.0 [interquartile range, 7.4–13.0]) were admitted to the PICU, mostly (86%) due to (imminent) circulatory failure. The majority received IV immunoglobulins (95%), steroids (83%), and vasopressors and/or inotropes (72%). Invasive respiratory support and extracorporeal membrane oxygenation were necessary in 7% and 2%, respectively. All patients survived. Fifty-eight patients (83%) attended 1-year follow-up. Although most patients had normal functional performance scores (Pediatric Cerebral Performance Category, Pediatric Overall Performance Category, and Functional Status Score), 62% still experienced physical sequelae: fatigue (40%), headaches (27%), and decreased exercise tolerance (19%). Cognitive, behavioral, and psychological problems were reported in 14%, 13%, and 23%, respectively. This resulted in 22% requiring ongoing healthcare utilization, 9% not being able to return to full-time school attendance and cessation of hobbies in 7%. CONCLUSIONS:. This is the first 1-year outcome study of MIS-C PICU patients to include both physical and psychosocial characteristics. One year after PICU admission, most children had normalized functional performance as measured by three validated performance scores. However, many still reported a variety of multidimensional sequelae at 1-year follow-up impacting daily life. This emphasizes the importance of continued investigative efforts and multidisciplinary follow-up programs to better understand pathophysiology and contributing factors to the MIS-C disease trajectory and initiate patient-specific interventions to improve outcome and social participation.http://journals.lww.com/10.1097/CCE.0000000000001213
spellingShingle Thomas C. Seijbel, BSc
Levi Hoste, MD
Corinne M. P. Buysse, MD, PhD
Karolijn Dulfer, PhD
Filomeen Haerynck, MD, PhD
Matthijs de Hoog, MD, PhD
Naomi Ketharanathan, MD, PhD
Multidimensional 1-Year Outcomes After Intensive Care Admission for Multisystem Inflammatory Syndrome in Children
Critical Care Explorations
title Multidimensional 1-Year Outcomes After Intensive Care Admission for Multisystem Inflammatory Syndrome in Children
title_full Multidimensional 1-Year Outcomes After Intensive Care Admission for Multisystem Inflammatory Syndrome in Children
title_fullStr Multidimensional 1-Year Outcomes After Intensive Care Admission for Multisystem Inflammatory Syndrome in Children
title_full_unstemmed Multidimensional 1-Year Outcomes After Intensive Care Admission for Multisystem Inflammatory Syndrome in Children
title_short Multidimensional 1-Year Outcomes After Intensive Care Admission for Multisystem Inflammatory Syndrome in Children
title_sort multidimensional 1 year outcomes after intensive care admission for multisystem inflammatory syndrome in children
url http://journals.lww.com/10.1097/CCE.0000000000001213
work_keys_str_mv AT thomascseijbelbsc multidimensional1yearoutcomesafterintensivecareadmissionformultisysteminflammatorysyndromeinchildren
AT levihostemd multidimensional1yearoutcomesafterintensivecareadmissionformultisysteminflammatorysyndromeinchildren
AT corinnempbuyssemdphd multidimensional1yearoutcomesafterintensivecareadmissionformultisysteminflammatorysyndromeinchildren
AT karolijndulferphd multidimensional1yearoutcomesafterintensivecareadmissionformultisysteminflammatorysyndromeinchildren
AT filomeenhaerynckmdphd multidimensional1yearoutcomesafterintensivecareadmissionformultisysteminflammatorysyndromeinchildren
AT matthijsdehoogmdphd multidimensional1yearoutcomesafterintensivecareadmissionformultisysteminflammatorysyndromeinchildren
AT naomiketharanathanmdphd multidimensional1yearoutcomesafterintensivecareadmissionformultisysteminflammatorysyndromeinchildren